Suppr超能文献

1例局部晚期乙状结肠癌患者在接受包括贝伐单抗/FOLFOX4方案的化疗后出现病理完全缓解

[A case of pathologically complete response in a patient with locally advanced sigmoid colon cancer after chemotherapy including bevacizumab/FOLFOX4].

作者信息

Mikami Youshi, Tamura Naoshi, Akiyama Masayuki, Muraoka Takeshi, Sakurai Urara, Sawabe Motoshi

机构信息

Dept. of Surgery, Ohta Hospital.

出版信息

Gan To Kagaku Ryoho. 2014 Jun;41(6):777-9.

Abstract

A 65-year-old man complaining of abdominal pain was admitted to our hospital. A diagnosis of colon ileus due to sigmoidal colon cancer was made. A stoma was created at the transverse colon, and elective surgery was scheduled. During the operation, the tumor was found to have invaded the bladder and the pelvic wall, making curative resection impossible. Chemotherapy consisting of bevacizumab/oxaliplatin, Leucovorin, and 5-fluorouracil(FOLFOX4, intravenous drip infusion every 2 weeks)was started. After 12 courses of treatment, remarkable shrinkage of the tumor was noted, which led us to perform a sigmoidectomy and partial resection of the bladder wall. A histopathological study of the surgically resected specimen showed no cancer cells. Recovery was uneventful and the patient was discharged on the 17th postoperative day. In cases of advanced colon cancer, complete response of the primary tumor with preoperative chemotherapy is very unusual. We conclude that chemotherapy with bevacizumab/FOLFOX4 plays a role in the management of advanced/unresectable colon cancer.

摘要

一名65岁男性因腹痛入院。诊断为乙状结肠癌所致结肠肠梗阻。在横结肠造口,并安排了择期手术。术中发现肿瘤已侵犯膀胱和盆腔壁,无法进行根治性切除。开始使用贝伐单抗/奥沙利铂、亚叶酸钙和5-氟尿嘧啶组成的化疗方案(FOLFOX4,每2周静脉滴注一次)。经过12个疗程的治疗,肿瘤明显缩小,促使我们进行了乙状结肠切除术和膀胱壁部分切除术。对手术切除标本的组织病理学研究显示未见癌细胞。恢复过程顺利,患者于术后第17天出院。在晚期结肠癌病例中,术前化疗使原发肿瘤完全缓解非常罕见。我们得出结论,贝伐单抗/FOLFOX4化疗在晚期/不可切除结肠癌的治疗中发挥作用。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验